¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cancer gene therapy."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • gene amplification
    À¯ÀüÀÚÁõÆø
  • gene analysis
    À¯ÀüÀںм®
  • gene cloning
    À¯ÀüÀÚŬ·Î´×, À¯ÀüÀÚº¹Á¦
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene defect
    À¯ÀüÀÚ°á¼Õ
  • gene deletion
    À¯ÀüÀÚ°á¼Õ
  • gene dosage compensation
    À¯ÀüÀÚ¿ë·®º¸»ó
  • gene expression
    À¯ÀüÀÚ¹ßÇö
  • gene family
    À¯ÀüÀÚ±º
  • gene frequency
    À¯ÀüÀÚºóµµ
  • gene genetics
    À¯ÀüÀÚÀ¯ÀüÇÐ
  • gene imbalance
    À¯ÀüÀÚºÒÆòÇü
  • gene map
    À¯ÀüÀÚÁöµµ
  • gene mapping
    À¯ÀüÀÚÀ§Ä¡ÁöÁ¤, À¯ÀüÀÚÁöµµÀÛ¼º
  • gene pool
    À¯ÀüÀÚÇ®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • embolic therapy
    »öÀüÄ¡·á, ¸·±âÄ¡·á
  • endocrine therapy
    ³»ºÐºñ¿ä¹ý
  • evocative group therapy
    Ç¥ÇöÁý´Ü¿ä¹ý
  • fever therapy
    ¹ß¿­¿ä¹ý
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý°¨½Ã
  • hyperbaric oxygenation therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • hypoglycemic shock therapy
    ÀúÇ÷´çÃæ°Ý¿ä¹ý, Àν¶¸°Ãæ°Ý¿ä¹ý
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • implosive therapy
    ³»Æø¿ä¹ý
  • intensity modulated radiation therapy
    °­µµº¯Á¶¹æ»ç¼±¿ä¹ý
  • interference current therapy
    °£¼·ÆÄÄ¡·á
  • interpersonal therapy
    ´ëÀοä¹ý
  • interventional therapy
    ÁßÀç¿ä¹ý
  • intraopertive radiation therapy
    ¼ö¼úÁß¹æ»ç¼±Ä¡·á
  • marriage therapy
    (¢¡couples therapy) ºÎºÎ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • postoperative radiation therapy
    (¼ö)¼úÈĹæ»ç¼±Ä¡·á
  • preoperative radiation therapy
    (¼ö)¼úÀü ¹æ»ç¼±Ä¡·á
  • prolonged sleep therapy
    Áö¼Ó¼ö¸é¿ä¹ý, Àå±â¼ö¸é¿ä¹ý(íåÑ¢â²ØùèþÛö).
  • protein therapy
    ´Ü¹é(Áú)¿ä¹ý(¡­èþÛö).
  • proton beam therapy
    ¾çÀÚ¼±Ä¡·á
  • psychobiological therapy
    Á¤½Å»ý¹°ÇÐÀû Ä¡·á(¡­ßæÚªùÊîÜö½èþ).
  • psychosocial therapy
    Á¤½Å»çȸÀû ¿ä¹ý
  • pulmonary physical therapy
    Æó¹°¸®¿ä¹ý.
  • radioactive isotope therapy unit
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÄ¡·á±â
  • radioimmunoglobulin therapy
    ¹æ»ç¸é¿ª ±Û·Îºí¸°Ä¡·á
  • radioiodine therapy
    ¹æ»ç¼º¿Á¼Ò Ä¡·á
  • radiolabeled immunoglobulin therapy
    ¹æ»ç¼ºÇ¥Áö¸é¿ª±Û·ÎºÒ¸°Ä¡·á
  • radium therapy
    ¶óµð¿òÄ¡·á
  • rational-emotive therapy
    À̼º°¨¼º¿ä¹ý(ìµàõÊïàõèþÛö)
  • reality therapy
    Çö½ÇÄ¡·á
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • bcg gene
    bcg À¯ÀüÀÚ(¡­ë¶îîí­)
  • bcl gene
    bcl À¯ÀüÀÚ
  • bcr-c-abl gene
    bcr-c-abl À¯ÀüÀÚ
  • beta-globin gene
    º£Å¸±×·ÎºóÀ¯ÀüÀÚ(¡­ë¶îîí­)
  • c4a gene
    C4A À¯ÀüÀÚ (¡­ë¶îîí­)
  • calcitonin-gene related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • complementary gene
    º¸Á·À¯ÀüÀÚ(ÜÍðëë¶îîí­), º¸Ã¼À¯ÀüÀÚ.
  • contiguous gene syndrome
    Á¢Ã˼º À¯ÀüÀÚ ÁõÈıº(ïÈõºàõë¶îîí­ñøý¦ÏØ)
  • contiguous gene syndrome
    ÀÎÁ¢ À¯ÀüÀÚ ÁõÈıº
  • control gene
    Á¦¾îÀ¯ÀüÀÚ(ð¤åÙë¶îîí­).
  • covering gene
    ÇǺ¹À¯ÀüÀÚ(¡­ë¶îîí­).
  • dcc gene
    DCC À¯ÀüÀÚ(¡­ë¶îîí­)
  • determinant gene
    °áÁ¤À¯ÀüÀÚ(̽ïÒë¶îîí­).
  • dominant autosomal gene
    ¿ì¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • RNA gene
    RNA À¯ÀüÀÚ(ë¶îîí­)
  • secretor gene
    ºÐºñÀÚ À¯ÀüÀÚ(ÝÂÝôíºë¶îîí­)
  • sensor gene
    ¼¾¼­ À¯ÀüÀÚ(ë¶îîí­)
  • sex-linked gene
    ¼º¿¬°ü À¯ÀüÀÚ(àõ֤μë¶îîí­)
  • silent gene
    ħ¹¬ À¯ÀüÀÚ(öØÙùë¶îîí­)
  • split gene
    ºÐÇÒ À¯ÀüÀÚ(ÝÂùÜë¶îîí­)
  • src gene
    src À¯ÀüÀÚ(ë¶îîí­)
  • structural gene
    ±¸Á¶ À¯ÀüÀÚ(ϰðãë¶îîí­)
  • sublethal gene
    ¾ÆÄ¡»ç À¯ÀüÀÚ(ä¬öÈÞÝë¶îîí­)
  • suppressor gene
    ¾ï¾Ð(ÀÚ)À¯ÀüÀÚ(åääâ(í­)ë¶îîí­)
  • wild-type gene
    ¾ß»ýÇü(å¯ßæúþ) À¯ÀüÀÚ(ë¶îîí­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
GAG glycosaminoglycan; group-specific antigen gene
GAS galactorrhea-amenorrhea syndrome; gastric acid secretion; gastrin; gastroenterology; general adaptat...
gp gene product; glycoprotein; group
GTA gene transfer agent; Glanzmann thrombasthenia; glycerol teichoic acid
HGM hog gastric mucosa; human gene mapping; human glucose monitoring
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
IST Immunosuppressive therapy
IMRT Intensity Modulated Radiation Therapy
ITU Intensive Therapy Unit
IIT Intensive insulin therapy
IORT Intra Operative Radiation Therapy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sero therapy
    Ç÷û ¿ä¹ý
    ¼¼Æ÷ °¨¿°Áõ °¡¿îµ¥ ¿Üµ¶¼Ò¿¡ ÀÇÇØ »ý±â´Â ÁúȯÀ̳ª ¹ìÀÇ ±³ÁõÀ» Ä¡·áÇÏ´Â ¹æ¹ý Áß ÇϳªÀÌ´Ù.
  • solid carbon dioxide therapy
    °íü ź»ê °¡½º ¿ä¹ý
  • splint therapy
    ±³ÇÕ ÀåÄ¡ ¿ä¹ý
  • substitution therapy
    º¸Ãæ ¿ä¹ý
    ³»ºÐºñ¼±ÀÇ ±â´É ºÎÀüÀ» º¸ÃæÇϱâ À§ÇÑ È£¸£¸óÀÇ Åõ¿©.
  • supervoltage roentgen therapy
    Ãʰí¾Ð X¼± Ä¡·á
  • supportive and symptomatic therapy
    Áõ»ó ¿ä¹ý
  • supportive therapy
    º¸Á¶ ¿ä¹ý, ÁöÁö¿ä¹ý
  • telecobalt therapy
    ÄÚ¹ßÆ® ¿ø°Ý Ä¡·á
  • thrombolytic therapy
    Ç÷Àü ¿ëÇØ Ä¡·á, Ç÷Àü ¿ëÇØ ¿ä¹ý
  • tongue blade therapy
    ¼³¾ÐÀÚ Ä¡·á
  • toxi-therapy
    µ¶¼Ò ÁÖ»ç ¿ä¹ý
  • ultrasound therapy
    ÃÊÀ½ÆÄ ¿ä¹ý
  • vital pulp therapy
    »ýȰ Ä¡¼ö Ä¡·á
  • ¥â-ray therapy
    º£Å¸¼± ¿ä¹ý
  • ¥ã-ray therapy
    °¨¸¶¼± ¿ä¹ý
    °¨¸¶¼±À» ÀÌ¿ëÇÏ¿© Á¾¾ç°ú °°Àº °ÍÀ» Ä¡·áÇÏ´Â ¹æ¹ý. °¨¸¶¼±Àº õ¿¬ÀÇ ¹æ»ç´É¹°Áú ¶Ç´Â ÀΰøÀûÀ¸·Î ¸¸µé¾îÁø ¹æ»ç¼º µ¿À§¿ø¼ÒÀÇ ¿øÀÚÇÙ¿¡¼­ ¹æ»çµÇ´Âµ¥, õ¿¬ÀÇ ¹æ»ç´É¹°ÁúÀº ´ëü·Î ¼±¿øÀ¸·Î¼­ÀÇ ¼±·®ÀÌ Àû±â ¶§¹®¿¡, ¶óµã ħ, ¶óµã°ü, ¶óµ·Ä§°ú °°Àº À̸¥¹Ù ¼Ò¼±¿øÀ» Á¾¾çÁ¶Á÷ ³»¿¡ Âñ·¯ ³Ö°Å³ª Á¾¾çÀÇ Ç¥¸é¿¡ ³ª¶õÈ÷ ºÙÀÌ´Â Ä¡·á¹ýÀ» ¸¹ÀÌ »ç¿ëÇÑ´Ù. ÀΰøÀûÀÎ ¹æ»ç¼º µ¿À§¿ø¼Ò´Â °í¹ßÆ® ħ°ú °°ÀÌ 10 mCi Á¤µµ±îÁöÀÇ ¼Ò¼±¿øÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ°í, ¼öõ Ci¶ó´Â ´ë¼±¿øÀ¸·Î ¿ø°ÝÁ¶»ç¹ýÀ» ½Ç½ÃÇÒ ¼öµµ ÀÖ´Ù. ÄÚ¹ßÆ® 60¿¡¼­ ¹æ»çµÇ´Â ¥ã¼±ÀÇ ¿¡³ÊÁö´Â ´ëü·Î 3,000 kVÀÇ X¼±°ú °°´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
nonsmall cell lung cancer A general classification for squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.
(12 Dec 1998)
infiltrating cancer <oncology> Cancer that has grown through the cell wall of the breast area, in which it originated, and into surrounding tissues.
(13 Nov 1997)
invasive cancer Cancer that has spread to surrounding tissue.
(16 Dec 1997)
invasive cervical cancer Cancer that has spread from the surface of the cervix to tissue deeper in the cervix or to other parts of the body.
(12 Dec 1998)
oat cell cancer A type of lung cancer in which the cells look like oats. Also called small cell lung cancer.
(12 Dec 1998)
oesophageal cancer Cancer of the oesophagus (the swallowing tube that passes from the throat to the stomach). The risk of cancer of the oesophagus is increased by long-term irritation of the oesophagus such as with smoking, heavy alcohol intake, and Barrett's oesophagitis. Cancer of the oesophagus can cause difficulty and pain with swallowing solid food. Diagnosis of oesophageal cancer can be made by barium X-ray of the oesophagus, and confirmed by endoscopy with biopsy of the cancer tissue.
(12 Dec 1998)
oral cancer Cancer within the mouth. Please see MedicineNet site on ral cancer for more information.
(12 Dec 1998)
ovarian cancer <gynaecology, oncology> A malignant tumour of the ovary is the leading cause of death from gynaecologic malignancies. Often diagnosed in later stages, symptoms include abdominal pain, increasing abdominal girth and abnormal uterine bleeding.
Birth control pill use is thought to reduce the risk of ovarian cancer.
(05 Jan 1998)
telangiectatic cancer A cancer with numerous dilated capillaries and "lakes" of blood within relatively large endothelium-lined channels.
(05 Mar 2000)
testicular cancer <oncology> A malignant growth that arises from a glandular cell in the testis.
Common symptoms include a painless testicular mass in a male between the ages of 15 and 35 years. Monthly self-examinations are recommended in those between the ages of 15 and 39 years of age.
(13 Jan 1998)
early stage breast cancer <oncology> Cancer is confined to the breast and has not spread to other sites in the body.
(16 Dec 1997)
thyroid cancer <oncology> A form of cancer that can occur in all age groups, particularly those who have had exposure to radiation.
Papillary carcinoma is the most common form of thyroid malignancy and usually affects women of child-bearing age. Symptoms include neck swelling, goitre, horse voice, cough, haemoptysis, diarrhoea and constipation.
Follicular carcinoma occurs with increased frequency in those who have had radiation exposure to the neck. Other risk factors include a family history of thyroid disease and history for goitre. Follicular carcinoma constitutes about 30% of all thyroid cancers. It has a greater rate of recurrence and metastasis than that of papillary carcinoma (the most common form of thyroid cancer). Symptoms include enlargement of the thyroid gland or neck swelling, change in voice, cough (occasionally bloody) and diarrhoea.
Papillary carcinoma is the most common thyroid cancer and usually affects women of child-bearing age.
Incidence: approximately in 1 in 1,000.
(02 Jan 1998)
encephaloid cancer An obsolete term for medullary carcinoma.
(05 Mar 2000)
epidermoid cancer A type of lung cancer in which the cells are flat and look like fish scales. Also called squamous cell carcinoma.
(12 Dec 1998)
epithelial cancer Any malignant neoplasm originating from epithelium, i.e., a carcinoma.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á